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Enterotoxigenic Escherichia coli (ETEC) cause significant diarrheal morbidity and mortality
in children of resource-limited regions, warranting development of effective vaccine strate-
gies. Genetic diversity of the ETEC pathovar has impeded development of broadly protec-
tive vaccines centered on the classical canonical antigens, the colonization factors and
heat-labile toxin. Two non-canonical ETEC antigens, the EtpA adhesin, and the EatA muci-
nase are immunogenic in humans and protective in animal models. To foster rational vac-
cine design that complements existing strategies, we examined the distribution and
molecular conservation of these antigens in a diverse population of ETEC isolates.
Methods
Geographically diverse ETEC isolates (n = 1159) were interrogated by PCR, immunoblot-
ting, and/or whole genome sequencing (n = 46) to examine antigen conservation. The most
divergent proteins were purified and their core functions assessed in vitro.
Results
EatA and EtpA or their coding sequences were present in 57.0% and 51.5% of the ETEC
isolates overall, respectively; and were globally dispersed without significant regional
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differences in antigen distribution. These antigens also exhibited >93% amino acid
sequence identity with even the most divergent proteins retaining the core adhesin and
mucinase activity assigned to the prototype molecules.
Conclusions
EtpA and EatA are well-conserved molecules in the ETEC pathovar, suggesting that they
serve important roles in virulence and that they could be exploited for rational vaccine
design.
Author summary
Enterotoxigenic Escherichia coli (ETEC) are a significant cause of childhood diarrhea in
low-middle income countries for which there is currently no vaccine. ETEC vaccine
approaches to date have focused on antigens known as colonization factors (CFs) and the
pathovar-defining toxins. However, both antigenic diversity of CFs and the lack of charac-
terized CF antigens in many strains has hindered deployment of broadly protective ETEC
vaccines. Nevertheless, more recent studies have identified additional ETEC virulence
molecules that could compliment canonical vaccine strategies. Here, we demonstrate that
two proteins, the EtpA adhesin and EatA mucinase, are present in a diverse, global collec-
tion of isolates, and are among the most highly conserved ETEC pathovar-specific anti-
gens to be identified, providing additional incentive to explore their utility in the rational
design of broadly protective ETEC vaccines.
Introduction
Enterotoxigenic Escherichia coli (ETEC) are a genetically heterogeneous group of pathogens
defined by the production of plasmid-encoded heat-labile (LT) and/or heat-stable (ST) entero-
toxins [1]. Diarrheal illness caused by ETEC ranges from mild to severe cholera-like disease
[2]. ETEC is a significant cause of severe diarrhea in young children of low-middle income
countries [3, 4], where it leads to tens of thousands of deaths each year. The burden of illness
expands substantially with hundreds of millions of less severe cases of diarrhea attributable to
ETEC [5]. Childhood infection with ETEC [5–8] is associated with substantial morbidity and
post-diarrheal sequelae including environmental enteropathy, malnutrition, growth stunting,
and cognitive impairment [9–12]. The strong association of malnutrition and deaths due to
other infectious diseases further amplifies the potential impact of an effective vaccine [4, 12,
13].
Given that a large proportion of the world population remains without ready access to
clean water or basic sanitation, vaccines targeting ETEC and other common enteric pathogens,
remain a high priority in efforts to prevent childhood diarrheal illness [14]. The canonical
approach to ETEC vaccine development is based on a classical virulence paradigm in which
the bacteria adhere to the small intestine via plasmid-encoded colonization factors (CFs) [15]
allowing delivery of their ST and/or LT enterotoxin payloads causing secretory diarrhea.
Although the relationship of anti-CF antibodies to protection following ETEC infections in
endemic areas has been difficult to establish [16], controlled human infection studies convinc-
ingly demonstrate that passive immunization against CFs, or CF tip adhesin molecules can
prevent symptomatic ETEC diarrhea [17]. Although most ETEC appear to encode CFs or CF-
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like chaperone-usher-pilus operons [18] 20–50% of isolates lack any of the 25 established and
immunologically distinct CFs that have been characterized to date [19, 20], potentially con-
founding development of a broadly protective vaccine focused exclusively on CFs, and
prompting the exploration of additional antigens, including toxoids that could collectively
afford broad-based protection [21–23].
Human challenge studies demonstrated that the ETEC H10407 strain cured of a virulence
plasmid encoding CFA/I was avirulent, engendering early enthusiasm for targeting CFs [24].
Notably, subsequent genetic and molecular pathogenesis studies identified two additional
pathovar-specific, non-canonical virulence loci on this plasmid; eatA, which encodes a mem-
ber of the serine protease autotransporters of Enterobacteriaceae (SPATE) family [25], and the
etpBAC two-partner secretion adhesin locus [26]. EatA has been shown to facilitate interaction
with epithelial cells by limiting accumulation of the secreted EtpA adhesin [27] and by degrad-
ing MUC2, the major mucin secreted by goblet cells in the intestinal mucosa [28]. EtpA is a
large (170kD) extracellular glycoprotein that forms a molecular bridge from the bacterial sur-
face to intestinal epithelia where it interacts with abundant N-acetylgalactosamine (GalNAc)
residues of mucosal glycoproteins [29]. Recently, EtpA was shown to interact preferentially
with GalNAc residues presented as the terminal glycan on the A blood group, thereby acceler-
ating bacterial adhesion and toxin delivery. This interaction may underlie the enhanced dis-
ease severity following ETEC infections in blood group A hosts [6, 30].
To date, studies of EtpA and EatA suggest that these non-canonical antigens could comple-
ment classical approaches to ETEC vaccine development. Each of the proteins have been
shown to protect against ETEC infection in a murine model of intestinal colonization [28, 31]
and are immunologically recognized following experimental human challenge [32] or natural
infection with ETEC [33].
Because underlying plasticity of E. coli genomes can complicate vaccine development [34],
antigenic conservation across a broad representation of isolates is of paramount importance
in ETEC antigen selection. Although an earlier study, focused primarily on isolates from Ban-
gladesh, suggested that both the eatA and etpBAC loci were present in a phylogenetically dis-
tributed collection of ETEC isolates [33], further studies are required to assess the global
distribution of each locus and the functional conservation of the respective proteins within the
genetically diverse ETEC pathovar.
In the present study, we examined the molecular and functional conservation of EatA and
EtpA in a large, unbiased collection of validated ETEC strains isolated from cases of symptom-
atic diarrhea in the Global Enteric Multicenter Study (GEMS) [4] complemented with isolates
from regions of the Western Hemisphere not represented in GEMS. The interrogation of this
global collection of isolates demonstrates that EtpA and EatA are among the most highly con-
served ETEC pathovar-specific virulence molecules discovered to date, findings that should
foster further exploration of their role in disease and as protective antigens.
Methods
Ethics statement
All bacterial samples analyzed in these studies were de-identified and obtained from previously
archived existing collections outlined in S5 Table.
Sample acquisition
To obtain a diverse and unbiased collection, well-validated ETEC isolates were obtained from
a variety of sources. These included 883 ETEC isolates from children with moderate-severe
diarrhea in the Global Enteric Multicenter Study (GEMS) obtained through the University of
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Maryland [4]. Toxin characterization for these isolates was performed at the study site as previ-
ously described [35] and verified using PCR with primers described in S1 Table. CF profiles
were determined by Roberto Vidal at Universidad de Chile using polymerase chain reaction as
described elsewhere [20]. Eight ETEC isolates were obtained from U.S. and Canadian adults
with traveler’s diarrhea while visiting Mexico [36], and an additional 40 isolates were provided
by the Minnesota Department of Health [37]. Those from Bangladesh (icddr,b) included 171
previously collected isolates [33] and 50 additional isolates collected in the course of routine
2% molecular surveillance studies of acute watery diarrhea conducted at icddr,b. Additional
clinical isolates from Chile [38], Colombia [39, 40], and elsewhere had also been previously
characterized by PCR and/or western blotting (S2 Table).
Antigen detection by PCR and immunoblotting
ETEC were grown overnight in 3 ml Luria Broth at 37˚C from frozen glycerol stock stored at
-80˚C. Total nucleic acids were extracted using the Wizard Genomic DNA Purification Kit
(Promega catalog #A1120) according to the provided protocol and resuspended in 200 μl
water. PCR was performed using primers in S1 Table and described in supporting methods.
Supernatants from the overnight cultures used for nucleic acid extraction underwent trichlo-
roacetic acid precipitation and immunoblotting as previously described [33]. Full details of the
immunoblotting protocol are available in supporting methods.
Adjudication of discordant results
Samples with discordant PCR/immunoblot data underwent repeat culture from the same
stock and DNA was extracted using phenol/chloroform extraction and ethanol precipitation
(supporting methods). Immunoblotting was also performed on the repeat culture. A third
assay on a separate culture was performed if repeat testing did not confirm our prior results. If
the third assay again gave differing or ambivalent results, such as non-specific PCR products,
the isolate was not included in our analysis (S1 Fig). EatA positive samples with negative PCR
and positive western blots were included as positive in our final analysis, as negative PCR data
may result from minor sequence divergence at the primer binding site(s).
Genome sequencing
A total of 46 EtpA positive strains representing diverse geographic origins, CFs, and toxin
profiles were selected for Illumina whole genome sequencing (S3 Table). Phenol/chloroform
extraction was performed on pelleted cells from 3 ml overnight cultures; etpA presence was
confirmed by PCR prior to whole genome sequencing. Automated dual indexed libraries
were constructed with 600ng of genomic DNA utilizing the KAPA Hyper PCR-free Library
Kit (KAPA Biosystems) on the SciClone NGS instrument (Perkin Elmer) targeting 350bp
inserts. The concentration of each library was accurately determined through qPCR (Kapa
Biosystems) in order to make 250pM library dilutions for the HiSeqX platform. 2x151bp
paired end sequence data generated approximately 2.2 Gb per sample. Sequencing runs were
completed according the manufacturer’s recommendations (Illumina Inc, San Diego, CA). A
subset of strains (S3 Table) underwent individual strain or pooled, indexed PacBio sequenc-
ing. SMRTbell libraries were prepared starting with 4ug material per each of 12 samples.
Samples were mechanically sheared using the Covaris AFA system and then size selected for
10kb fragments using PacBio’s BluePippin system. 500ng per sample of fragmented material
(as quantified by Qubit fluorometer) were used to build a single, pooled library. This bar-
coded library was sequenced on a single SMRT cell using PacBio Sequel 2.0 chemistry. Indi-
vidual libraries were de-multiplexed from the pool after sequencing using PacBio’s SMRT
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Link. The H10407 and Jurua 18/11 samples followed the same method through shearing, but
then 1ug of 10kb fragmented material was used to generate 2 additional libraries that were
sequenced on the PacBio RSII using P6-C4 chemistry and assembled using HGAP4 default
settings within the SMRT assembler. A hybrid assembly of the 12 indexed samples was per-
formed using the SPAdes assembler. Trimmomatic cleaned, paired end Illumina data and
PacBio Sequel subread data for each sample were fed to the SPAdes assembler using default
assembly parameters. Job parameters included ’- -threads 4’ and ’- -memory 29’, recruiting 4
cpus and 29Gb of memory per hybrid assembly. These hybrid assemblies proved more con-
tiguous than earlier HGAP 4 assemblies (using default HGAP4 arguments) over the etpBAC
locus.
Sequence alignment and phylogenetic trees
Whole genome sequence was trimmed using Trimmomatic version 0.36 [41], then mapped to
the H10407 p948 plasmid as a reference (GenBank: FN649418.1) using HISAT2 version 2.1.0
(https://ccb.jhu.edu/software/hisat2/index.shtml) using default settings. Consensus sequence
was obtained for the H10407 etpA gene (GenBank: NC_017724) using the integrated genomics
viewer (http://software.broadinstitute.org/software/igv/) default settings [42]. Raw reads from
previously published isolates were downloaded from the GenBank’s SRA and were mapped to
the same reference plasmid (Assembly: ASM21047v1) to confirm the veracity of our method
(S3 Table, Bioproject PRJNA526881). Whole genome consensus sequence was uploaded to
European Bioinformatics Institute and phylogenetic trees were generated using Clustal Omega
(https://www.ebi.ac.uk/Tools/msa/clustalo/) and visualized using FigTree version 1.4.3 (http://
tree.bio.ed.ac.uk/software/figtree/).
Recombinant protein purification
The most divergent strains were selected based on their observed distance in assembled phylo-
genetic trees described above. jf4927 and jf4894 (S4 Table) expression strains were grown over-
night in 100 ml Luria Broth with 100 μg/ml ampicillin and 15 μg/ml chloramphenicol then
diluted to 4 L until reaching an OD 600 of 0.6. Expression was induced with 0.0002% (w/v)
arabinose for 6 hours at 37˚C. After centrifugation, culture supernatants were concentrated
using 100kD Molecular Weight Cutoff tangential-flow filter (Millipore). The secreted his-
tagged protein was purified using immobilized metal affinity chromatography as described
[30, 43]. Strain jf5003 expressing EatA from strain 700241 was utilized for recombinant pro-
tein expression and purification as previously described with the omission of ammonium sul-
fate precipitation [28].
Functional assays
EtpA binding to blood group A-expressing HT-29 cells and the CRISPR α1-3-N-acetylgalacto-
saminyltransferase deletion line (IE6), generating an isogenic blood group O line [44], was
assessed using immunofluorescence (supporting methods) and fluorescence signal was quanti-
fied using Volocity software (v6.3).
The rate of recombinant EatA (30 μg) cleavage of N-Succinyl-Ala-Ala-Pro-Leu p-nitroani-
lide, a common substrate for serine proteases, was performed as previously described without
the inclusion of ZnCl2 [25] while MUC2 cleavage was performed as described [28] (supporting
methods).
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Statistics
A master database of metadata was maintained in Excel 2010 and imported into SPSS (v24) for
analysis including determinations of means and 95% confidence intervals (S2 Table). Chi-
square analysis was used to determine differences in etpA/EtpA or eatA/EatA distribution
between geography, study origin, and each colonization factor or toxin. Under or over-repre-
sentation for plasmid associated genes was determined using binomial distributions in Excel
(2016) and adjusted for multiple comparisons with a value of<0.05 determining significance
(https://www.sdmproject.com/utilities/?show=FDR).
Results
Global conservation of EatA and EtpA
Rational vaccine design necessitates a thorough understanding of antigenic conservation
throughout a diverse population. Given the extraordinary genetic plasticity of E. coli [45], the
diversity of canonical ETEC target antigens [19, 20], and the worldwide distribution of ETEC,
we sought an unbiased and global approach to comprehensively determine the molecular dis-
tribution of these candidate antigens. Utilizing isolates collected from the GEMS study [4]
which included 7 sites in Africa and Asia, complemented with additional isolates obtained
from patients in Bangladesh, Chile [38], Colombia [39, 40], the Minnesota Department of
Health [37], and Mexico [36], we employed genetic and immunologic detection methods to
determine the distribution of both antigens (S2 Table). There was strong concordance between
the identification of either etpA or eatA genes by PCR with production of the corresponding
protein determined by immunoblotting (r = 0.82 for eatA/EatA and 0.92 for etpA/EtpA).
Overall, these antigens were identified in at least half of all isolates with the eatA gene and/or
EatA protein present in 57.0% (95% CI 54.2–59.9%) and etpA gene and/or EtpA protein
detected in 51.5% (48.6–54.4%). Combined, 73.3% (70.7–75.8%) of all isolates encode either
EatA or EtpA (Table 1).
Geographical variation in ETEC antigen conservation may occur for multiple reasons
including founder effects, clonality due to localized epidemics, or sampling within a limited
timeframe. However, we found no appreciable difference in the occurrence of either antigen
according to geographical distribution (Table 1, eatA/EatA p = 0.80, etpA/EtpA p = 0.81, either
antigen p = 0.42, Chi-squared testing). Similarly, variation between studies could also arise for
technical reasons such as differences in isolation procedures, culture or storage techniques,
and temporal trends during sample collection. Nevertheless, we found no differences in the
distribution of these antigens based on the collection (S5 Table, Chi-square testing for eatA/
EatA p = 0.706, etpA/EtpA p = 0.214, or either p = 0.220).
Table 1. Distribution of coding regions and/or protein expression for EatA and EtpA.
Region Total Isolates eatA or EatA etpA or EtpA eatA/EatA or etpA/EtpA
N % 95%CI N % 95%CI N % 95%CI
Asia 524 301 57.4 53.2–61.7 278 53.1 48.8–57.3 391 74.6 70.9–78.4
Africa 516 297 57.6 53.3–61.8 258 50.0 45.7–54.3 378 73.3 69.4–77.1
North, Central, and South America 105 55 52.4 42.7–62.1 54 51.4 41.7–61.2 70 66.7 57.5–75.8
Europe or Unknown 14 8 57.1 27.5–86.8 7 50.0 20.0–80.0 10 71.4 44.4–98.5
Total 1159 661 57 54.2–59.9 597 51.5 48.6–54.4 849 73.3 70.7–75.8
�N = Number of positive isolates for specified condition
https://doi.org/10.1371/journal.pntd.0007825.t001
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To account for potential plasmid loss that could impact determination of antigen distribu-
tion, we verified the presence of genes encoding ETEC-defining toxins (S1 Fig). Eighty-four of
the original 1243 isolates (6.8%) were determined not to be ETEC or to have lost their toxin-
encoding plasmids, consistent with prior estimates of the frequency of plasmid loss due to cul-
ture passage alone [16, 46]. The majority of excluded strains were from the GEMS dataset (77
of 84, 91.7%).
EatA and EtpA conservation relative to colonization factors and toxins
EatA or EtpA could augment current vaccine strategies by expanding antigenic valency and by
targeting different virulence mechanisms [47, 48]. To further assess the utility of EatA and
EtpA as candidate antigens, we determined their conservation relative to each of the major
ETEC colonization factors. In general, we found that either EtpA or EatA were conserved
among isolates which expressed major colonization factors (CFA/I, CS1, CS2, CS3, and CS7).
However, similar to earlier surveys conducted in Bangladesh [33], EtpA was underrepresented
in strains that express CS4, CS5, and CS6, Fig 1). Encouragingly, while 23.9% of strains lacked
an identifiable CF, eatA/EatA or etpA/EtpA were found in nearly half of these isolates (115 of
254, 45.3%), suggesting that these antigens could complement canonical approaches by
expanding antigenic coverage. We also examined the distribution of EatA or EtpA in combina-
tion with individual CFs having a baseline occurrence of>10% (Fig 2). As predicted, given the
underrepresentation of EtpA with Cs6 expressing isolates, the greatest increases are observed
when combining CS6 with EtpA. Similar to the canonical CFs [20], we also found that the
eatA and etpBAC loci were more commonly found in ST and ST/LT strains than those produc-
ing only LT.
EtpA sequence and functional conservation
The large and globally diverse strain collection affords the opportunity to identify sequence
variation that may alter either the function or immunogenic epitopes of EatA and EtpA. We
Fig 1. EatA or EtpA co-existence within ETEC strains expressing unique colonization factors and toxin types. Number for column
headings represents the total number positive for the specified condition. Isolates expressing both CFs and the designated non-canonical
antigen are depicted.
https://doi.org/10.1371/journal.pntd.0007825.g001
Non-canonical ETEC antigen conservation
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performed whole genome sequencing (Illumina) of 46 EtpA-expressing strains of which 29 co-
expressed EatA and supplemented our collection with sequence available in GenBank (S3
Table). The selected strains represent diverse geographies, toxin profiles, and CFs in an
attempt to maximize potential sequence heterogeneity.
Notably, the overall EtpA sequence identity was high (93.6–100%, N = 56) and compara-
ble to sequence diversity of eltAB genes, encoding the heat-labile toxin of ETEC [20, 49].
Likewise, when the minor sequence variations in etpA sequences were mapped onto the
prototype sequence of the molecule from H10407 (Accession NC_017724) and used to gen-
erate different phylogenic clusters, there was no clear association of any particular sequence
cluster with geographic location (Fig 3). Using whole genome phylogrouping [50], each
of the sequenced genomes mapped to phylogroups A and B1 (S2 Fig), where we observed
unexpected yet significant overrepresentation of E. coli phylogroups within EtpA clusters,
suggesting certain phylogroups are permissive to or co-evolved with distinct ETEC
plasmids.
Short-read sequencing of etpA can be confounded by multiple, large repetitive sequences
located at the 3’ region of the gene spanning 3.34 kb. Therefore, to confirm the sequence of the
etpA repeat region, we performed additional long read sequencing (PacBio) of etpA from
ETEC strains H10407, Jurua 18/11, and 100169. The resulting de novo assemblies were then
compared to sequence assemblies generated using short-read (Illumina) technology. H10407
and Jurua 18/11 were individually sequenced by PacBio and assembled using HGAP4 default
settings with mean read length of 10.8 kb for H10407 and 12.0 kb for Jurua 18/11. Indexed
PacBio sequencing of 100169 yielded sub-reads of 3.8 kb as described in materials and meth-
ods. Very few differences were observed between the sequences generated by PacBio vs Illu-
mina methodologies with (96.7% of bases identical for 1001696, 98.7 for Jurua 18/11, and
100% for H10407). Collectively, these data suggest that EtpA exhibits very little sequence varia-
tion over its geographic distribution.
EtpA from H10407 binds preferentially to N-acetylgalactosamine expressed in the con-
text of A blood group glycans on the intestinal mucosa, likely accounting for the increased
disease severity observed in individuals with this blood group [6, 30]. To assess functional
conservation of the protein, we cloned the most divergent etpA genes, expressed and puri-
fied the corresponding recombinant EtpA proteins, and examined their interaction with
blood group A glycans. Similar to the H10407 prototype molecule, EtpA from these diver-
gent strains exhibited preferential binding to blood group A carbohydrates expressed on the
surface of enterocytes (Fig 4), suggesting functional conservation across a broad representa-
tion of ETEC.
Fig 2. Percentage of ETEC strains expressing unique antigens alone or in combination with each other. The percentage of ETEC
strains expressing either antigen is presented. Only CFs found in� 10% of the collection are included. Antigen combinations were
determined for isolates expressing either antigen.
https://doi.org/10.1371/journal.pntd.0007825.g002
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EatA sequence and functional conservation
We also assessed potential sequence and functional differences in EatA expressing isolates.
The percent amino acid identities for EatA ranged from 94.3 to 100% (N = 38) relative to the
H10407 reference sequence. The EatA sequences cluster in a similar fashion to EtpA, a finding
we expect as both genes are encoded on the same plasmid in H10407 (Fig 5). Importantly, eval-
uation of the predicted EatA protein sequence demonstrated complete conservation of the cat-
alytic residues comprised of H134, D162, and S267 (S3 Fig). Similarly, comparison of five
available eatA sequences from etpA-negative genomes in Genbank (S3 Table) [51] demon-
strated>96.6% sequence identity and retention of the catalytic triad.
The most divergent eatA sequence was cloned and recombinant passenger domain of EatA
(rEatAp) was then purified to assess proteolytic activity. We first determined the proteolytic
activity of EatA using the synthetic peptide Suc-Ala-Ala-Pro-Leu (AAPL) coupled to p-nitroa-
nilide which when enzymatically cleaved produces the readily detectable yellow indicator,
4-nitroaniline [25]. We found that similar to EatA from H10407, rEatAp from ETEC strain
700241 cleaved AAPL, (Fig 6A). Likewise, rEatAp derived from H10407 and 700241 degraded
MUC2 (Fig 6B), providing further evidence that the minor degrees of sequence divergence
observed within the predicted EatA peptide sequence did not affect functional activity of the
enzyme.
Fig 3. Phylogenetic distribution of EtpA sequences and associated metadata. Five clusters of EtpA were identified using Clustal
Omega and FigTree software. Isolates marked with an asterisk denote sequences downloaded from the NCBI as external references (S3
Table). Within boxes, asterisks represent significant under (e.g., EatA absence in cluster 4) or over representation of the specified
variable between clusters as calculated using binomial distributions for each variable. For CFs, “None” designates no CF was identified
by PCR. Unknown means we have no data to support the presence or absence of a CF or were not included in the phylogroup analysis.
Significant p-values were adjusted for multiple comparisons (� = p< 0.05).
https://doi.org/10.1371/journal.pntd.0007825.g003
Non-canonical ETEC antigen conservation
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Discussion
The recognized diversity of canonical target molecules and the potential complexity inherent
in formulating broadly protective ETEC vaccines has driven the pursuit of novel strategies [52,
53]. Emerging pathogenesis studies suggest that additional surface-expressed antigens could
complement ETEC canonical CF-centered approaches. Genetic loci encoding two secreted vir-
ulence proteins not currently targeted in ETEC vaccines, EatA and EtpA, were initially discov-
ered in ETEC H10407 on the same plasmid that encodes CFA/I [54]. Studies thus far have
demonstrated that these antigens contribute to ETEC virulence, are highly immunogenic dur-
ing natural and experimental infections, and afford protection against infection in an animal
Fig 4. EtpA function is conserved. (A) Immunofluorescence microscopy of EtpA bound to HT-29 WT cells
expressing Blood Group A sugars or HT29 A-/- CRISPR deletion mutant generating functional blood group O cells,
EtpA detected with anti-EtpA antibodies. (B) Quantitation of mean fluorescent values normalized to DAPI (nuclei)
signal using Volocity software. Statistical differences determined by Kruskal-Wallis testing followed by Dunn’s test for
multiple comparisons with p<0.05 considered significant.
https://doi.org/10.1371/journal.pntd.0007825.g004
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Fig 5. Phylogenetic distribution of EtpA sequences and associated metadata. Phylogenetic differences between EatA isolates and
associated metadata using the same methods as in Fig 1. No statistics were determined for this data set due to small numbers and
inherent bias in the data.
https://doi.org/10.1371/journal.pntd.0007825.g005
Fig 6. Mucinase activity of EatA is retained. (A) Purified recombinant EatA degrades the synthetic protein Suc-Ala-
Ala-Pro-Leu-p-anilimide in a colorimetric assay measuring the rate of release of p-anilimide. 2 independent
experiments with 3 replicates total, medians with 95% CI are shown, (p = 0.1, Mann-Whitney U). (B) Degradation of
MUC2 by recombinant EatA from H10407 and strain 700241. Purified EatA and MUC2 from LS174T cells (~540 kDa)
were incubated together with mucin degradation (~300 kDa) assessed by western blotting, 2 independent experiments
performed.
https://doi.org/10.1371/journal.pntd.0007825.g006
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model [28, 31–33]. These promising initial results led to current efforts to ensure that these
antigens are sufficiently conserved across isolates to warrant further investigation of their util-
ity as vaccine antigens. As molecular conservation remains an essential benchmark in evaluat-
ing candidate antigens, the present studies were performed to provide more accurate estimates
of the global distribution and molecular sequence conservation of EtpA and EatA. To avoid
limitations of earlier studies derived from one geographic location or biased collections where
the intent is to maximize diversity [33, 55–57], we interrogated well-validated ETEC isolates of
known provenance from symptomatic illness collected over a broad geographic distribution.
Our findings affirm the conclusions from the prior studies and expand the knowledge base to
more diverse geographies.
The studies reported here suggest that both EtpA and EatA are among the most highly con-
served ETEC pathovar-specific antigens described to date. Moreover, by sequencing a geo-
graphically and phenotypically diverse subset of ETEC isolates we found that both antigens
exhibit substantial molecular sequence conservation and retain core virulence functions across
a range of isolates. Ongoing work seeks to identify conserved and protective epitopes for ratio-
nal vaccine design. Collectively, these features could simplify rational vaccine design.
No ETEC pathovar-specific protein, including either the LT or ST toxins that define ETEC,
is universally conserved in every strain. Because ST-producing strains appear to predominate
among ETEC associated with symptomatic illness, recent studies have focused on the preva-
lence of canonical vaccine target antigens among ST+ETEC. Similar to canonical CF targets,
we also find that eatA and etpA are more frequently associated with ST-producing strains rela-
tive to LT-only isolates. Both loci were originally identified on the p948 plasmid in ETEC
H10407 which encodes eatA, etpA, and sta2 (STh), while the p666 plasmid encodes sta1 (STp)
and genes for LT (eltA and eltB). Although it is possible that the eatA and etpBAC loci are simi-
larly linked on plasmids in other strains, the resolution of present sequencing data is not suffi-
cient to support the contention that these loci are inextricably linked to those encoding STh.
It is important to examine the findings of the present study relative to other potential target
molecules. Data from recent immunoproteome studies have demonstrated that ETEC infec-
tion induces mucosal antibody responses to EatA, EtpA, as well as canonical ETEC vaccine
antigens [32]. Notably, these studies also detected immune responses to highly conserved,
chromosomally encoded proteins, such as flagellin [58], making them potentially attractive
candidate antigens that could protect against multiple E. coli pathovars in addition to ETEC.
Whether vaccination with these core antigens, which are shared with the small population of
commensal E. coli, would adversely impact the human intestinal microbiota is currently
unknown [59]. Likewise, it is not known whether the immune response to these conserved
proteins that follows natural infections with ETEC could contribute to non-diarrheal sequelae
linked to these infections. At present, selectively targeting a compilation of pathovar-specific
antigens could offer a rational approach to a vaccine that affords broad-based coverage.
The ideal strategy for incorporation of these antigens into the development of a highly effi-
cacious and broadly protective vaccine will need to be determined. However, EtpA and EatA
could be adopted in a multivalent approach that targets complementary virulence characteris-
tics and extends antigenic valency. Similarity in virulence strategies between ETEC and Borde-
tella pertussis [60] may offer an important template for rational vaccine development. Both
pathogens produce toxins which induce cyclic nucleotides (pertussis toxin vs LT/ST), utilize
two-partner secretion hemagglutinin exoprotein adhesin molecules (filamentous hemaggluti-
nin [FHA] vs EtpA), fimbrial adhesins (pertussis fimbriae vs CFs), and surface expressed or
secreted autotransporter molecules important for virulence (pertactin vs EatA). Present acellu-
lar pertussis vaccines that incorporate toxoids, fimbriae, pertactin, and FHA [61] could there-
fore provide a valuable paradigm for the rational design of ETEC vaccines that combine novel
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antigens highlighted here with emerging LT and ST toxoids, and CFs selected to achieve broad
coverage against a diverse population of ETEC.
The broad representation of EatA and EtpA in a diverse and geographically distributed
population of ETEC isolated from symptomatic cases of diarrheal illness would appear to sup-
port recent in vitro, and animal studies, as well as controlled human infection model data sug-
gesting that these antigens play an important role in the molecular pathogenesis of disease.
These findings combined with the established immunogenicity of these proteins should
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